TECHNEUTRAL

TECH Return on Equity (ROE) Analysis

9.0%

Higher than 43% of Healthcare sector peers

Updated 29h ago·SEC filings & market data

Key Takeaway

Return on equity (ROE) measures how much profit a company generates from each dollar of shareholders’ equity, so Bio-Techne’s 9.0% means it earns $0.09 for every $1 of equity invested.

Sector Performance

43th percentile

TECH

9.0%

Sector Median

11.3%

Sector Avg

72.2%

Prior Period

5.3%(Aug 2026)

↑ Improving

📊

Deep Analysis

Return on equity (ROE) measures how much profit a company generates from each dollar of shareholders’ equity, so Bio-Techne’s 9.0% means it earns $0.09 for every $1 of equity invested.

That level sits just below the Healthcare sector median of 9.6%, placing the company at the 48th percentile among peers—essentially mid-pack. The trend data is limited: year-over-year change is N/A, while the quarter-over-quarter change is +69.8%, moving from 5.3% to 9.0% in the most recent period. With a near-sector-average ROE and a sharp recent rise, the risk profile is balanced—there is no sign of underperformance, but the metric’s short history offers limited evidence of sustained improvement. This mixed view directly supports the overall NEUTRAL verdict, as the metric neither pushes the stock into an opportunity nor signals a clear risk.

Frequently Asked Questions

What does the Return on Equity (ROE) tell investors about TECH?

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

How is the Return on Equity (ROE) calculated?

Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.

How does TECH's Return on Equity (ROE) compare to its sector?

TECH's Return on Equity (ROE) of 9.0% compares to a Healthcare sector median of 11.3%, placing it in the 43th percentile.

Who are TECH's closest peers by Return on Equity (ROE)?

The closest Healthcare peers by Return on Equity (ROE) include: ABT (12.5%), ALGN (10.1%), TMO (13.5%), VEEV (13.9%), DGX (14.6%).

📚

Learn More About Return on Equity (ROE)

What Is Return on Equity (ROE) and Is Higher Always Better?

Return on equity ROE measures how efficiently a company generates profit from shareholder capital. Learn how to decompose ROE using DuPont analysis and why high leverage can make it dangerous—with Apple and JPMorgan examples.

The Formula

Net Income / Shareholders' Equity

Why It Matters

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.